The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche
Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study.
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Incyte; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; Pierre Fabre; Roche/Genentech
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)
 
Thomas Gajewski
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; FORMA Therapeutics; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Evelo (Inst)
 
Christian Caglevic
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Lilly; MSD
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Medivation; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb
Other Relationship - Boehringer Ingelheim
 
Stéphane Dalle
Employment - Sanofi
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Ana Arance
No Relationships to Disclose
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Jean-Jacques Grob
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Roche
 
Tae Min Kim
No Relationships to Disclose
 
Lev V. Demidov
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
 
James M. G. Larkin
Honoraria - Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sectra
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; GlaxoSmithKline; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sectra
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Roche/Genentech
 
James Anderson
Employment - Merck
 
Janet E. Maleski
Employment - Incyte
Stock and Other Ownership Interests - Incyte
Travel, Accommodations, Expenses - Incyte
 
Mark M. Jones
Employment - Incyte
Stock and Other Ownership Interests - Incyte
Travel, Accommodations, Expenses - Incyte
 
Scott J. Diede
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Tara C. Mitchell
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Roche (Inst)